{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:31:37Z","timestamp":1775658697931,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[1999,3,12]],"date-time":"1999-03-12T00:00:00Z","timestamp":921196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,4,1]]},"DOI":"10.1038\/sj.bjc.6690298","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T13:47:09Z","timestamp":1032270429000},"page":"1870-1878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["p21\/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer"],"prefix":"10.1038","volume":"79","author":[{"given":"M A","family":"Anttila","sequence":"first","affiliation":[]},{"given":"V-M","family":"Kosma","sequence":"additional","affiliation":[]},{"given":"J","family":"Hongxiu","sequence":"additional","affiliation":[]},{"given":"J","family":"Puolakka","sequence":"additional","affiliation":[]},{"given":"M","family":"Juhola","sequence":"additional","affiliation":[]},{"given":"S","family":"Saarikoski","sequence":"additional","affiliation":[]},{"given":"K","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[1999,3,12]]},"reference":[{"key":"BF6690298_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/02841869609098526","volume":"8","author":"G Auer","year":"1996","unstructured":"Auer, G., Einhorn, N., Nilsson, B., Silfversward, C. & Sjovall, K. (1996). Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol 8: 93\u201398.","journal-title":"Acta Oncol"},{"key":"BF6690298_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00004347-199710000-00011","volume":"16","author":"J Backe","year":"1997","unstructured":"Backe, J., Gassel, A. M., Hauber, K., Krebs, S., Bartek, J., Caffier, H., Kreipe, H-H, Muller-Hermelink, H-K & Dietl, J. (1997). p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein. Int J Gynecol Pathol 16: 361\u2013368.","journal-title":"Int J Gynecol Pathol"},{"key":"BF6690298_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ijc.2910630502","volume":"63","author":"N Barboule","year":"1995","unstructured":"Barboule, N., Mazars, P., Baldin, V., Vidal, S., Jozan, S., Martel, P. & Valette, A. (1995). Expression of p21WAF1\/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int J Cancer 63: 611\u2013615.","journal-title":"Int J Cancer"},{"key":"BF6690298_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.44.1.7","volume":"44","author":"CC Boring","year":"1994","unstructured":"Boring, C. C., Squires, T. S., Tong, T. & Montgomery, S. (1994). Cancer statistics, 1994. CA Cancer J Clin 44: 7\u201326.","journal-title":"CA Cancer J Clin"},{"key":"BF6690298_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<140::AID-PATH745>3.0.CO;2-A","volume":"181","author":"IK Bukholm","year":"1997","unstructured":"Bukholm, I. K., Nesland, J. M., Karesen, R., Jacobsen, U. & Borresen, A. L. (1997). Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol 181: 140\u2013145.","journal-title":"J Pathol"},{"key":"BF6690298_CR6","unstructured":"Cancer Committee of the International Federation of Gynecology, Obstetrics (1989). Staging Announcement: FIGO Cancer Committee. Gynecol Oncol 25: 383\u2013385."},{"key":"BF6690298_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D. R. (1972). Regression models and life tables with discussion. J Stat Soc B 34: 187\u2013192.","journal-title":"J Stat Soc B"},{"key":"BF6690298_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/A:1005752829260","volume":"43","author":"SG Diab","year":"1997","unstructured":"Diab, S. G., Yu, Y., Hilsenbeck, S. G., Allred, D. C. & Elledge, R. M. (1997). WAF1\/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat 43: 99\u2013103.","journal-title":"Breast Cancer Res Treat"},{"key":"BF6690298_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO;2-6","volume":"179","author":"C Doglioni","year":"1996","unstructured":"Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F. & Barbareschi, M. (1996). p21\/WAF1\/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 179: 248\u2013253.","journal-title":"J Pathol"},{"key":"BF6690298_CR10","first-page":"1301","volume":"5","author":"A Elbendary","year":"1994","unstructured":"Elbendary, A., Berchuck, A., Davis, P., Havrilesky, I., Bast, R. C. Jr, Iglehart, J. D. & Marks, J. R. (1994). Transforming growth factor beta 1 can induce CIP1\/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 5: 1301\u20131307.","journal-title":"Cell Growth Differ"},{"key":"BF6690298_CR11","first-page":"1571","volume":"2","author":"AA Elbendary","year":"1996","unstructured":"Elbendary, A. A., Cirisano, F. D., Evans, A. C., Davis, P. L., Iglehart, J. D., Marks, J. R. & Berchuk, A. (1996). Relationship between p21 expression and mutation of p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2: 1571\u20131575.","journal-title":"Clin Cancer Res"},{"key":"BF6690298_CR12","first-page":"1169","volume":"54","author":"WS El-Deiry","year":"1994","unstructured":"El-Deiry, W. S., Harper, J. W., O\u2019Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W. & Vogelstein, B. (1994). WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169\u20131174.","journal-title":"Cancer Res"},{"key":"BF6690298_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817\u2013825.","journal-title":"Cell"},{"key":"BF6690298_CR14","first-page":"2910","volume":"55","author":"WS El-Deiry","year":"1995","unstructured":"El-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W. & Vogelstein, B. (1995). Topological control of p21WAF1\/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910\u20132919.","journal-title":"Cancer Res"},{"key":"BF6690298_CR15","first-page":"81","volume":"49","author":"A Engeland","year":"1995","unstructured":"Engeland, A., Haldorsen, T., Tretli, S., Hakulinen, T., Horte, L. G., Luostarinen, T., Schou, G., Sigvaldason, H., Storm, H. H. & Tulinius, H. (1995). Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis: a collaborative study of five Nordic cancer registries. APMIS Suppl 49: 81\u201383.","journal-title":"APMIS Suppl"},{"key":"BF6690298_CR16","unstructured":"Finnish Cancer Registry (1997). Cancer incidence in Finland 1995. Cancer statistics of the National Research and Development Center for Welfare and Health. Cancer Society of Finland, No. 58"},{"key":"BF6690298_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/gyno.1995.1026","volume":"56","author":"GG Garzetti","year":"1995","unstructured":"Garzetti, G. G., Ciavattini, A., Gotteri, G., De Nictolis, M., Stramazzotti, D., Lucarini, G. & Biagini, G. (1995). Ki 67 immunostaining (MIB1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol 56: 169\u2013174.","journal-title":"Gynecol Oncol"},{"key":"BF6690298_CR18","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M","volume":"79","author":"Y Gomyo","year":"1997","unstructured":"Gomyo, Y., Ikeda, M., Osaki, M., Tatebe, S., Tsujitani, S., Ikeguchi, M., Kaibara, N. & Ito, H. (1997). Expression of p21 (waf1\/cip1\/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 79: 2067\u20132072.","journal-title":"Cancer"},{"key":"BF6690298_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.1997.382","volume":"76","author":"N Harada","year":"1997","unstructured":"Harada, N., Gansauge, S., Gansauge, F., Gause, H., Shimoyama, S., Imaizumi, T., Mattfield, T., Schoenberger, M. H. & Beger, H. G. (1997). Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1 in pancreatic cancer. Br J Cancer 76: 299\u2013305.","journal-title":"Br J Cancer"},{"key":"BF6690298_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805\u2013816.","journal-title":"Cell"},{"key":"BF6690298_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/gyno.1994.1138","volume":"53","author":"R Henriksen","year":"1994","unstructured":"Henriksen, R., Strang, P., Wilander, E., Backstrom, T., Tribukait, B. & Oberg, K. (1994). p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol 53: 301\u2013306.","journal-title":"Gynecol Oncol"},{"key":"BF6690298_CR22","first-page":"2178","volume":"56","author":"JJ Herod","year":"1996","unstructured":"Herod, J. J., Eliopoulos, A. G., Warwick, J., Niedobitek, G., Young, L. S. & Kerr, D. J. (1996). The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res 56: 2178\u20132184.","journal-title":"Cancer Res"},{"key":"BF6690298_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<318::AID-PATH925>3.0.CO;2-0","volume":"183","author":"K Ito","year":"1997","unstructured":"Ito, K., Sasano, H., Matsunaga, G., Sato, S., Yajima, A., Nasim, S. & Garret, C. (1997). Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma. J Pathol 183: 318\u2013324.","journal-title":"J Pathol"},{"key":"BF6690298_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/bjc.1996.528","volume":"74","author":"Y Ito","year":"1996","unstructured":"Ito, Y., Kobayashi, T., Takeda, T., Komoike, Y., Wakasugi, E., Tamaki, Y., Tsujimoto, M., Matsuura, N. & Monden, M. (1996). Expression of p21 (WAF1\/CIP1) protein in clinical thyroid tissues. Br J Cancer 74: 1269\u20131274.","journal-title":"Br J Cancer"},{"key":"BF6690298_CR25","first-page":"3397","volume":"9","author":"H Jiang","year":"1994","unstructured":"Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E. & Fisher, P. B. (1994). Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1\/CIP1, expression in the absence of p53. Oncogene 9: 3397\u20133406.","journal-title":"Oncogene"},{"key":"BF6690298_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<529::AID-IJC9>3.0.CO;2-5","volume":"74","author":"M Jiang","year":"1997","unstructured":"Jiang, M., Shao, Z. M., Wu, J., Lu, J. S., Yu, L. M., Yuan, J. D., Han, Q. X., Shen, Z. Z. & Fontana, J. A. (1997). p21\/waf1\/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer 74: 529\u2013534.","journal-title":"Int J Cancer"},{"key":"BF6690298_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF6690298_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/1097-0142(19951001)76:7<1201::AID-CNCR2820760716>3.0.CO;2-L","volume":"76","author":"PJ Klemi","year":"1995","unstructured":"Klemi, P. J., Pylkk\u00e4nen, L., Kiilholma, P., Kurvinen, K. & Joensuu, H. (1995). p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer 76: 1201\u20131208.","journal-title":"Cancer"},{"key":"BF6690298_CR29","first-page":"643","volume":"81","author":"MF Kohler","year":"1993","unstructured":"Kohler, M. F., Kerns, B. J., Humphrey, P. A., Marks, J. R., Bast, R. C. Jr & Berchuck, A. (1993a). Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81: 643\u2013650.","journal-title":"Obstet Gynecol"},{"key":"BF6690298_CR30","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/jnci\/85.18.1513","volume":"85","author":"MF Kohler","year":"1993","unstructured":"Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke Pearson, D. L., Soper, J. T., Bast, R. C. Jr & Berchuck, A. (1993b). Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 85: 1513\u20131519.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690298_CR31","first-page":"1279","volume":"13","author":"S Kondo","year":"1996","unstructured":"Kondo, S., Barna, B. P., Kondo, Y., Tanaka, Y., Casey, G., Liu, J., Morimura, T., Kaakaji, R., Peterson, J. W., Werbel, B. & Barrett, G. H. (1996). WAF1\/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13: 1279\u20131285.","journal-title":"Oncogene"},{"key":"BF6690298_CR32","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P","volume":"75","author":"MA Levesque","year":"1995","unstructured":"Levesque, M. A., Katsaros, D., Yu, H., Zola, P., Sismondi, P., Giardina, G. & Diamandis, E. P. (1995). Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 75: 1327\u20131338.","journal-title":"Cancer"},{"key":"BF6690298_CR33","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W. H., Felix, J., Jones, L. A., Hall, F. L. & Press, M. F. (1997). WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol 150: 167\u2013175.","journal-title":"Am J Pathol"},{"key":"BF6690298_CR34","first-page":"1319","volume":"12","author":"A Marchetti","year":"1996","unstructured":"Marchetti, A., Doglioni, C., Barbareschi, M., Buttita, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Angeletti, C. A., Palma, P. D. & Bevilacqua, G. (1996). p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 12: 1319\u20131324.","journal-title":"Oncogene"},{"key":"BF6690298_CR35","first-page":"2979","volume":"51","author":"JR Marks","year":"1991","unstructured":"Marks, J. R., Davidoff, A. M., Kerns, B. J., Humphrey, P. A., Pence, J. C., Dodge, R. K., Clarke Pearson, D. L., Iglehart, J. D., Bast, R. C. Jr & Berchuck, A. (1991). Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51: 2979\u20132984.","journal-title":"Cancer Res"},{"key":"BF6690298_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jcp.50.8.645","volume":"50","author":"MS Mateo","year":"1997","unstructured":"Mateo, M. S., Saez, A. L., Sanchez-Beato, M., Garcia, P., Sanchez-Verde, L., Martinez, J. C., Orradre, J. L. & Piris, M. A. (1997). Expression of p21WAF1\/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53. J Clin Pathol 50: 645\u2013653.","journal-title":"J Clin Pathol"},{"key":"BF6690298_CR37","first-page":"3391","volume":"54","author":"P Michieli","year":"1994","unstructured":"Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. (1994). Induction of WAF1\/CIP1 by a p53-independent pathway. Cancer Res 54: 3391\u20133395.","journal-title":"Cancer Res"},{"key":"BF6690298_CR38","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/bjc.1997.276","volume":"75","author":"M Ogawa","year":"1997","unstructured":"Ogawa, M., Maeda, K., Onoda, N., Chung, Y. S. & Sowa, M. (1997). Loss of p21WAF1\/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 75: 1617\u20131620.","journal-title":"Br J Cancer"},{"key":"BF6690298_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0046-8177(97)90280-X","volume":"28","author":"JP Palazzo","year":"1997","unstructured":"Palazzo, J. P., Mercer, W. E., Kovatich, A. J. & McHugh, M. (1997). Immunohistochemical localization of p21WAF1\/CIP1 in normal, hyperplastic, and neoplastic uterine tissues. Hum Pathol 28: 60\u201366.","journal-title":"Hum Pathol"},{"key":"BF6690298_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker, S. L., Tong, T., Bolden, S. & Wingo, P. A. (1997). Cancer statistics, 1997. CA Cancer J Clin 47: 5\u201327.","journal-title":"CA Cancer J Clin"},{"key":"BF6690298_CR41","volume-title":"International Histological Classification of Tumors","author":"SF Serov","year":"1973","unstructured":"Serov, S. F., Scully, R. & Sobin, L. H. (1973). Histological typing of ovarian tumours. International Histological Classification of Tumors, no 9: Geneva: WHO"},{"key":"BF6690298_CR42","first-page":"3407","volume":"9","author":"MS Sheikh","year":"1994","unstructured":"Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordonez, J. V. & Fontana, J. A. (1994). Mechanisms of regulation of WAF1\/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407\u20133415.","journal-title":"Oncogene"},{"key":"BF6690298_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1525-1438.1997.00457.x","volume":"7","author":"K Shigemasa","year":"1997","unstructured":"Shigemasa, K., Hu, C., West, C. M., Moon, S. H., Parham, G. P., Parmley, T. H., Korourian, S., Baker, V. V. & O\u2019Brien, T. J. (1997). p21: a monitor of p53 dysfunction in ovarian neoplasia. Int J Gynecol Cancer 7: 296\u2013303.","journal-title":"Int J Gynecol Cancer"},{"key":"BF6690298_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/ajcp\/107.6.684","volume":"107","author":"E Wakasugi","year":"1997","unstructured":"Wakasugi, E., Kobayashi, T., Tamaki, Y., Ito, Y., Miyashiro, I., Komoike, Y., Takeda, T., Shin, E., Takatsuka, Y., Kikkawa, N., Monden, T. & Monden, M. (1997). p21 (Waf1\/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol 107: 684\u2013691.","journal-title":"Am J Clin Pathol"},{"key":"BF6690298_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.1995.13.1.70","volume":"13","author":"AG van der Zee","year":"1995","unstructured":"van der Zee, A. G., Hollema, H., Suurmeijer, A. J., Krans, M., Sluiter, W. J., Willemse, P. H., Aalders, J. G. & de Vries, E. G. (1995). Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncol 13: 70\u201378.","journal-title":"J Clin Oncol"},{"key":"BF6690298_CR46","first-page":"1043","volume":"5","author":"M Wan","year":"1994","unstructured":"Wan, M., Zweizig, S., D\u2019Ablaing, G., Zheng, J., Velicescu, M. & Dubeau, L. (1994). Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas. Int J Oncol 5: 1043\u20131048.","journal-title":"Int J Oncol"},{"key":"BF6690298_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00004347-199704000-00011","volume":"16","author":"BA Werness","year":"1997","unstructured":"Werness, B. A., Jobe, J. S., DiCioccio, R. A. & Piver, M. S. (1997a). Expression of the p53 induced tumor suppressor p21waf1\/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry. Int J Gyn Pathol 16: 149\u2013155.","journal-title":"Int J Gyn Pathol"},{"key":"BF6690298_CR48","first-page":"578","volume":"10","author":"BA Werness","year":"1997","unstructured":"Werness, B. A., Wang, H-Q, Chance, J. & Goldstein, D. J. (1997b). p53-independent expression of p21waf1\/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol 10: 578\u2013584.","journal-title":"Mod Pathol"},{"key":"BF6690298_CR49","first-page":"668","volume":"55","author":"W Zhang","year":"1995","unstructured":"Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. & Mercer, W. E. (1995). p53-independent induction of WAF1\/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte\/macrophage differentiation. Cancer Res 55: 668\u2013674.","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690298","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6690298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T23:59:39Z","timestamp":1733788779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3,12]]},"references-count":49,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[1999,4,1]]}},"alternative-id":["BF6690298"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690298","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3,12]]},"assertion":[{"value":"18 June 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 1998","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 1998","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 1999","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2011","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}